The Claim
Quercetin, a flavonoid found in coffee, inhibits the oligomerization of amyloid-beta (with an IC50 of 10.3 μM) and its fibrillization, does not inhibit tau fibrillization, and promotes α-synuclein oligomerization at high concentrations, indicating a selective and potentially complex role in the aggregation of neurodegenerative proteins.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
A compound in coffee called quercetin might stop some harmful protein clumps linked to Alzheimer’s from forming, but it doesn’t stop another type linked to tau, and at high doses, it might even make a different protein clump more — so its effects are mixed and not simple.
See the scientific wording
Quercetin, a flavonoid in coffee, inhibits amyloid-beta oligomerization (IC50 = 10.3 μM) and fibrillization but does not inhibit tau fibrillization and promotes α-synuclein oligomerization at high concentrations, indicating a selective and potentially complex role in neurodegenerative protein aggregation.
What the research says
1 studyStudy: Phenylindanes in Brewed Coffee Inhibit Amyloid-Beta and Tau Aggregation
The study found that a chemical in coffee called quercetin stops harmful clumps of amyloid-beta proteins from forming, doesn’t affect tau proteins, and actually makes alpha-synuclein clumps worse at high doses — just like the claim said.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.